← Leaderboards
Zhenbang Chen
Meharry Medical College
$5,285,254
Attributed
$5,285,254
Total exposure
5
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $553K · FY2009–23$1M$750K$500K$250K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$5,285,254 · 5
By mechanism
U54$3,488,558 · 4
R01$1,796,696 · 1
Top collaborators
No co-investigators on record.
Most similar at Meharry Medical College
Same institution · by research overlap
- Chandrasekhar Thota$134,776
Others in their field
Top investigators on “Malignant Neoplasm Of Prostate”
- David Heimbrook · Leidos Biomedical Research, Inc.$255,843,614
- Leonard Freedman · Leidos Biomedical Research, Inc.$63,277,106
- Walter John Curran · Thomas Jefferson University$61,298,085
- Norman Wolmark · Nsabp Foundation, Inc.$54,888,134
- James J. Dignam · University Of Chicago$48,310,409
- Laurence H Baker · University Of Michigan At Ann Arbor$43,366,962
Research focus
Malignant Neoplasm Of ProstateIncidenceRegulationPten GeneMolecularMouse ModelProstatic NeoplasmsMutant Strains MicePathway InteractionsGrowthAfrican AmericanCancer Health DisparityIn VivoAmericanMalignant NeoplasmsOncogenicProto-Oncogene Proteins C-AktTumor ProgressionCell AgingInsightMutatePhosphoric Monoester HydrolasesCancer PatientCells
Grant awards (23)
Investigator Development Core$553,015
U54 · FY2023 · MD · contact PI
Mechanism and oncogenic role of lysine demethylase KDM5B in prostate cancer$277,334
U54 · FY2021 · MD · contact PI
Mechanism and oncogenic role of lysine demethylase KDM5B in prostate cancer$282,703
U54 · FY2020 · MD · contact PI
Novel mechanisms of SKP2 and AR signaling on the suppression of prostate cancer$186,240
U54 · FY2020 · CA · contact PI
Mechanism and oncogenic role of lysine demethylase KDM5B in prostate cancer$41,756
U54 · FY2020 · MD · contact PI
Mechanism and oncogenic role of lysine demethylase KDM5B in prostate cancer$41,275
U54 · FY2020 · MD · contact PI
Mechanism and oncogenic role of lysine demethylase KDM5B in prostate cancer$308,187
U54 · FY2019 · MD · contact PI
Novel mechanisms of SKP2 and AR signaling on the suppression of prostate cancer$158,668
U54 · FY2019 · CA · contact PI
Mechanism and oncogenic role of lysine demethylase KDM5B in prostate cancer$313,704
U54 · FY2018 · MD · contact PI
Novel mechanisms of SKP2 and AR signaling on the suppression of prostate cancer$192,065
U54 · FY2018 · CA · contact PI
Mechanism and oncogenic role of lysine demethylase KDM5B in prostate cancer$307,062
U54 · FY2017 · MD · contact PI
Novel mechanisms of SKP2 and AR signaling on the suppression of prostate cancer$194,311
U54 · FY2017 · CA · contact PI
Novel mechanisms of SKP2 and AR signaling on the suppression of prostate cancer$196,848
U54 · FY2016 · CA · contact PI
Molecular Mechanisms of SKP2 Targeting on Prostate Cancer Progression$27,380
U54 · FY2015 · CA · contact PI
Molecular Mechanisms of SKP2 Targeting on Prostate Cancer Progression$29,898
U54 · FY2014 · CA · contact PI
Pten-loss Dysregulated Pathways in Prostate Cancer$339,020
R01 · FY2013 · MD · contact PI
Molecular Mechanisms of SKP2 Targeting on Prostate Cancer Progression$117,398
U54 · FY2013 · CA · contact PI
Pten-loss Dysregulated Pathways in Prostate Cancer$362,588
R01 · FY2012 · MD · contact PI
Molecular Mechanisms of SKP2 Targeting on Prostate Cancer Progression$129,594
U54 · FY2012 · CA · contact PI
Pten-loss Dysregulated Pathways in Prostate Cancer$362,588
R01 · FY2011 · MD · contact PI
Molecular Mechanisms of SKP2 Targeting on Prostate Cancer Progression$131,120
U54 · FY2011 · CA · contact PI
Pten-loss Dysregulated Pathways in Prostate Cancer$366,250
R01 · FY2010 · MD · contact PI
Pten-loss Dysregulated Pathways in Prostate Cancer$366,250
R01 · FY2009 · MD · contact PI